Andreas Harstrick

10.8k citations
131 papers · 8.9k · 1 hit paper · h-index 36

Impact in

  • Oncology top 0.5%
    • Colorectal Cancer Treatments and Studies
    • Cancer Treatment and Pharmacology
    • HER2/EGFR in Cancer Research
  • Hepatology top 1%
    • Hepatocellular Carcinoma Treatment and Prognosis

Papers in

Andreas Harstrick

127 papers receiving 8.5k citations

Andreas Harstrick's Hit Papers

Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer 2004 · 4.2k citations
4.2k0+7+14Years since publication10002.0k3.0k4.0k

Peers

Andreas Harstrick
Comparison fields: 5 of 119
  • Oncology 5.0k
  • Hepatology 657
  • Otorhinolaryngology 346
  • Pulmonary and Respiratory Medicine 2.3k
  • Pathology and Forensic Medicine 789
Replace Otilia Dalesio with:
Otilia Dalesio Netherlands
Lee S. Rosen United States
P. Koralewski Poland
Federica Perrone Italy
Helen X. Chen United States
Mark F. Kozloff United States
A.T. van Oosterom Netherlands
Javier Sastre Spain
Yoshinori Ito Japan
Axel Hinke Germany
Andreas Harstrick relative to Otilia Dalesio Netherlands Otilia Dalesio's profile →
Citations per field
00.5×1.5×2×2.5×
Otilia Dalesio · 1×
Citations per year

Countries citing papers authored by Andreas Harstrick

Since Specialization
Citations

This map shows the geographic impact of Andreas Harstrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Harstrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Harstrick more than expected).

Fields of papers citing papers by Andreas Harstrick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Harstrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Harstrick. The network helps show where Andreas Harstrick may publish in the future.

Co-authors

The 25 scholars most cited alongside Andreas Harstrick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andreas Harstrick Line = papers co-authored together Andreas Harstrick links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 131 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
Hit paper breakdown →
20044215
2 2005407
3 2001280
4 1998259
5 2003235
6 1997175
7 1998154
8 2006140
9 1996131
10 1999118
11 1996113
12 1999110
13
Phase I clinical and pharmacokinetic study of titanocene dichloride in adults with advanced solid tumors.
1998107
14 199397
15
Clinical phase I dose escalation and pharmacokinetic study of high-dose chemotherapy with treosulfan and autologous peripheral blood stem cell transplantation in patients with advanced malignancies.
200097
16 199188
17 199683
18
Chemotherapeutic strategies in metastatic colorectal cancer: an overview of current clinical trials.
199282
19 199680
20 200577

About Andreas Harstrick

Andreas Harstrick is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Pathology and Forensic Medicine and Hematology, having authored 131 papers that have together received 8.9k indexed citations. Recurring topics across this work include Testicular diseases and treatments (35 papers), Colorectal Cancer Treatments and Studies (30 papers), Cancer Treatment and Pharmacology (22 papers), Cancer therapeutics and mechanisms (21 papers), Gastric Cancer Management and Outcomes (15 papers), Lung Cancer Treatments and Mutations (14 papers), Chemotherapy-induced organ toxicity mitigation (13 papers) and Neuroblastoma Research and Treatments (11 papers). The work is most often cited by research in Oncology (5.0k citations), Hepatology (657 citations), Otorhinolaryngology (346 citations), Pulmonary and Respiratory Medicine (2.3k citations) and Pathology and Forensic Medicine (789 citations). Andreas Harstrick has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Yves Humblet, Chris Verslype, David Cunningham, Eric Van Cutsem, Harry Bleiberg, Ian Chau, David Khayat, Matthias Mueser, Salvatore Siena and Armando Santoro. Their work appears in journals such as European Journal of Cancer, Annals of Oncology, Journal of Clinical Oncology, Anti-Cancer Drugs and Cancer Chemotherapy and Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact